DS19-02

Main Content

The impact of pre-apheresis health related quality of life on peripheral blood progenitor cells yield and donor’s health and outcome.

Study #: DS19-02

Study Status: Published

Presentation(s)

2021, ASH (Poster)

The impact of pre-apheresis Health Related Quality of Life on peripheral blood progenitor cell yield and donor’s health and outcome: Secondary analysis of Patient-Reported Outcome Data from the RDSafe and BMT CTN 0201 Clinical Trials.

Citation

Farhadfar N, Ahn KW, Bo-Subait S, Logan B, Stefanski HE, Hsu JW, Panch S, Confer D, Liu H, Badawy SM, Beitinjaneh A, Diaz MA, Hildebrandt GC, Kelkar AH, Lazarus HM, Murthy HS, Preussler JM, Schears RM, Sharma A, Poel M, Bruce JG, Pulsipher MA, Shaw BE, Wingard JR, Switzer GE.

Transplantation and Cellular Therapy. 2022, Sep 01: 28(9): 28(9):603.e1-603.e7. doi: 10.1016/j.jtct.2022.05.042. Epub 2022, Jun 07. PMCID:PMC9427696.

PubMed

PMID: 35688325

Abstract